These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 2418780

  • 1. Enhancement by muramyldipeptides of the activities of early-type inducers of interferon.
    Ikeda S, Matsuda Y, Nishimura C.
    Antiviral Res; 1985 Dec; 5(6):345-53. PubMed ID: 2418780
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs.
    Ikeda S, Negishi T, Nishimura C.
    Antiviral Res; 1985 Aug; 5(4):207-15. PubMed ID: 2412489
    [Abstract] [Full Text] [Related]

  • 3. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice.
    Ishihara C, Hamada N, Yamamoto K, Iida J, Azuma I, Yamamura Y.
    Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426
    [Abstract] [Full Text] [Related]

  • 4. In vitro regulation by muramyl dipeptide of interferon production from peripheral blood mononuclear cells of healthy volunteers.
    Al-Attiyah RJ, Bahr GM, Strannegard O, Chedid L, Behbehani K.
    Int J Immunopharmacol; 1988 Dec; 10(8):931-8. PubMed ID: 2463973
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of N-acetyl-muramyl-L-alanyl-D-isoglutamine on interferon production in mice by Newcastle disease virus.
    Sakuma T, Azuma M, Yoshida I.
    J Gen Virol; 1984 May; 65 ( Pt 5)():999-1003. PubMed ID: 6202835
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Interferon-stimulating activity of muramoyl dipeptide glycosides].
    Zholobak NM, Spivak NIa, Zemliakov AE, Tsikalov VV, Chupakhina TA, Kur'ianov VO, Chirva VIa.
    Mikrobiol Z; 2007 May; 69(4):33-9. PubMed ID: 17977450
    [Abstract] [Full Text] [Related]

  • 12. Effect of MDP-Lys(L18), a derivative of MDP, on enhancing host resistance against Hantaan virus infection in newborn mice.
    Yoo YC, Yoshimatsu K, Hatsuse R, Tamura M, Yoshida R, Tono-oka S, Arikawa J, Azuma I.
    Vaccine; 1995 Oct; 13(14):1300-5. PubMed ID: 8585284
    [Abstract] [Full Text] [Related]

  • 13. Suppression of Sendai virus growth by treatment with N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl-L-lysine in mice.
    Ishihara C, Mizukoshi N, Iida J, Kato K, Yamamoto K, Azuma I.
    Vaccine; 1987 Dec; 5(4):295-301. PubMed ID: 2448969
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
    Ogawa T, Kotani S, Shimauchi H.
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin.
    Ogawa T, Kotani S, Shimauchi H.
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542
    [Abstract] [Full Text] [Related]

  • 16. Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus.
    Fukushima A, Yoo YC, Yoshimatsu K, Matsuzawa K, Tamura M, Tono-oka S, Taniguchi K, Urasawa S, Arikawa J, Azuma I.
    Vaccine; 1996 Apr; 14(6):485-91. PubMed ID: 8782344
    [Abstract] [Full Text] [Related]

  • 17. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
    Nagao S, Sato K, Osada Y.
    Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
    [Abstract] [Full Text] [Related]

  • 18. Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virus.
    Korngold R, Blank KJ, Murasko DM.
    J Immunol; 1983 May; 130(5):2236-40. PubMed ID: 6187846
    [Abstract] [Full Text] [Related]

  • 19. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
    Nagao S, Sato K, Osada Y.
    Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
    [Abstract] [Full Text] [Related]

  • 20. Seasonal modulation of interferon response in spotted sousliks (Spermophilus suslicus).
    Kandefer-Szerszeń M, Meczyński S, Borowska L, Szuster-Ciesielska A, Rzeski W.
    Arch Immunol Ther Exp (Warsz); 1994 Jul; 42(5-6):425-31. PubMed ID: 8572902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.